Additionally, for the CRC liver metastasis setting we found that DNA methylation markers investigated in cfDNA from liquid biopsies provided superior AUC values as the already established tumour marker Septin9, providing a rationale for implementing those markers in the clinical routine. This evidence concerns the gene SEPTIN9 and neoplasm.